Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to…
TechCrunch reports: Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
This technology story centres on the United States.
Why it matters
Changes in the tech sector often reach consumers quickly through the devices, apps and online services they use every day.
Key details
- Location
- United States · Americas
- Reported by
- TechCrunch
- First reported
- Key names
- Intero Biosystems
- Section
- Technology
Sources
This is an independent summary. Read the full, original reporting from the publisher:
Read the full story at TechCrunchSpotted an error? Request a correction · How this summary was produced
Related Stories
AI can act exactly like a human, but we still don't think it's conscious
Researchers found that participants considered even the most responsive AI less conscious than the least responsive human.
Inside Amazon’s robotic arms race and what it means for the future of human work
Despite deploying so many robots, Amazon is also the second-largest corporate employer in the world, with more than 1.5 million full-time and…
Scientists discover a human brain gene that can jump through DNA
Called BC200, the gene evolved millions of years ago from a mobile piece of DNA known as a transposon, but unlike most genes that arose this way, it…
White House spokesperson Katie Zacharia’s law career faces scrutiny
Katie Zacharia has repeatedly claimed to be a lawyer, but critics question whether she was ever licensed.
Ricursive Intelligence is betting on AI-designed chips to help solve the compute crisis
The founders detailed how their startup is developing AI that can design chips, learn from each iteration, and improve subsequent designs, all with…
Flock CEO defends surveillance technology amid national backlash: ‘We shouldn’t pause progress’
At TechCrunch Disrupt, Flock CEO Garrett Langley defended his company's surveillance technology despite growing privacy concerns, arguing that its…
Gudea leverages AI to help organizations prevent social media crises before they erupt
A seemingly insignificant post—whether it involves AI-generated misinformation, hate speech, or a damaging rumor—can quickly snowball into a much…
McKinsey is making job applicants spar with a fake AI client
Consulting firm McKinsey & Company is going to ask some entry-level candidates to have a 10-minute conversation with an AI simulation of a client as…